CORT News and Press, Corcept Therapeutics Incorporated From 02/15/24

2024-02-15 16:23:49 ET More on Corcept Therapeutics Corcept Therapeutics Q4 2023 Earnings Preview Corcept Therapeutics reports prelim Q4 rev above estimate Seeking Alpha’s Quant Rating on Corcept Therapeutics Historical earnings data for Corcept Therap...

MENLO PARK, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the...

MENLO PARK, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the...

Propanc Biopharma Inc (PPCB) is expected to report for Q2 2024 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 Arch Resources Inc. Class A (ARCH) is expected to report $6.9 for Q4 2023 Bloom Energy Corporation Class A (BE) is expected to report $-0.0...

MENLO PARK, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report fourth quarter and full-year 2023 financial results and provide a corporate update on February 15, 2024. The company will also host a conference call that day at 5...

MENLO PARK, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the...

2024-01-22 08:26:07 ET Losers: Archer Daniels Midland Co. ADM -15% on leave amid accounting probe, trims FY 2023 earnings guidance . B. Riley Financial ( RILY ) -15% issues financial Statement . Bionomics Ltd. ( BNOX ) -11% provides a Review of 20...

2024-01-08 08:45:52 ET More on Corcept Therapeutics Analyzing Corcept's Strategic Shift In A Competitive Pharma Landscape Corcept Therapeutics Incorporated (CORT) Q3 2023 Earnings Call Transcript Canaccord Genuity sees Corcept sell-off as buying opportunity B...

MENLO PARK, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncology, metabolism and neurology disorders by modulating the effects of the hormo...

2024-01-07 02:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...